Adenovirus delivered short hairpin RNA targeting a conserved site in the 5′ non-translated region inhibits all four serotypes of dengue viruses

PLoS Neglected Tropical Diseases

Volumn 6, Issue 7, 2012, Pages

  Korrapati, Anil Babu ^a   Swaminathan, Gokul ^a   Singh, Aarti ^a   Khanna, Navin ^a   Swaminathan, Sathyamangalam ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CIS ACTING ELEMENT; NONSTRUCTURAL PROTEIN 1; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; VIRUS ANTIGEN; ANTIVIRUS AGENT; BIOLOGICAL PRODUCT; DRUG CARRIER;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; RNA INTERFERENCE; SEROTYPE; VIRAL GENE DELIVERY SYSTEM; VIRUS INHIBITION; VIRUS PLAQUE; VIRUS REPLICATION; ANIMAL; CELL LINE; DRUG EFFECT; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN ADENOVIRUS; PHYSIOLOGY;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL AGENTS; CELL LINE; DENGUE VIRUS; DRUG CARRIERS; GENETIC VECTORS; HUMANS; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 84864605865     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001735     Document Type: Article

References (43)

1. Swaminathan S, Khanna N, (2009) Dengue: recent advances in biology and current status of translational research. Curr Mol Med 9: 152-173.
2. Swaminathan S, Batra G, Khanna N, (2010) Dengue vaccines: state of the art. Exp Opin Ther Patents 20: 819-835.
3. Lindenbach BD, Thiel HJ, Rice CM, (2007) Flaviviridae: The viruses and their replication. In: Knipe DM, Howley PM, editors. Fields of Virology, 5th edition pp. 1101-1152 Wolters Kluwer and Lippincott Williams & Wilkins, Philadelphia.
4. WHO Factsheet N°117 (2012) Dengue and dengue haemorrhagic fever. Available: www.who.int/mediacentre/factsheets/fs117/en/. Accessed 2012 Jun 18.
5. Vaughn DW, Greene S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.
6. Libraty DH, Endy TP, Houng HSH, Green S, Kalayanarooj S, et al. (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185: 1213-1221.
7. van Rij RP, Andino R, (2006) The silent treatment: RNAi as a defense against virus infection in mammals. Trends Biotechnol 24: 186-193.
8. Dykxhoorn DM, Lieberman J, (2006) Silencing viral infection. PLoS Med 3: e242.
9. Castonotto D, Rossi JJ, (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457: 426-433.
10. Elbashir SM, Harborth J, Lendecker W, Yalcin A, Weber K, et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
11. Brummelkamp TR, Bernards R, Agami R, (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
12. Paddison PJ, Caudy AA, Bersnstein E, Hannon GJ, Conklin DS, (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16: 948-958.
13. Xia H, Mao Q, Paulson HL, Davidson BL, (2002) siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20: 1006-1010.
14. Uprichard SL, Boyd B, Althage A, Chisari FV, (2005) Clerance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci USA 102: 773-778.
15. Zhang W, Singam R, Hellermann G, Kong X, San Juan H, et al. (2004) Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. Genet Vac Ther 2: 8.
16. Kumar P, Lee SK, Shankar P, Manjunath N, (2006) A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med 3: e96.
17. Cullen BR, (2006) Induction of stable RNA interference in mammalian cells. Gene Ther 13: 503-508.
18. Leonard JN, Schaffer DV, (2006) Antiviral RNAi therapy: emerging approaches for hitting a moving target. Gene Ther 13: 532-540.
19. Grimm D, Kay MA, (2006) Therapeutic short hairpin RNA expression in the liver: viral targets and vectors. Gene Ther 13: 563-575.
20. Adelman ZN, Blair CD, Carlson JO, Beaty BJ, Olson KE, (2001) Sindbis virus-induced silencing of dengue viruses in mosquitoes. Insect Mol Biol 10: 265-273.
21. Franz AWE, Sanchez-Vargas I, Adelman ZN, Blair CD, Beaty BJ, et al. (2006) Engineering RNAi-based transgenic resistance against dengue virus type 2 in Aedes aegypti. Proc Natl Acad Sci USA 103: 4198-4203.
22. Mathur G, Sanchez-Vargas I, Alvarez D, Olson KE, Marinotti O, et al. (2010) Transgene-mediated suppression of dengue viruses in the salivary glands of the yellow fever mosquito, Aedes aegypti. Insect Mol Biol 19: 753-763.
23. Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, et al. (2010) Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol 84: 2490-2501.
24. Stein DA, Perry ST, Buck MD, Oehmen CS, Fischer MA, et al. (2011) Inhibition of dengue virus infections in cell cultures and in AG129 mice by small interfering RNA targeting a highly conserved sequence. J Virol 85: 10154-10166.
25. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, et al. (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124: 1283-1298.
26. He TC, Zhou S, DaCosta LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514.
27. Khanam S, Khanna N, Swaminathan S, (2006) Induction of antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors. Vaccine 24: 6513-6525.
28. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam V, (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545-551.
29. Durbin AP, Karron RA, Sun W, Vaughn DW, Reynolds MJ, et al. (2001) Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30-nucleotide deletion in its 3′-untranslated region. Amer J Trop Med Hyg 65: 405-413.
30. Gentry MK, Henchal EA, McCown JM, Brandt WE, Dalrymple JM, (1992) Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Amer J Trop Med Hyg 31: 548-555.
31. Filomatori CV, Lodeiro MF, Alvarez DE, Samsa MM, Pietrasanta L, et al. (2006) A 5′ RNA element promotes dengue virus RNA synthesis on a circular genome. Genes & Dev 20: 2238-2249.
32. Zeng L, Falgout B, Markoff L, (1998) Identification of specific nucleotide sequences within the conserved 3′-SL in the dengue type 2 virus genome required for replication. J Virol 72: 7510-7522.
33. Alvarez DE, Lodeiro MF, Ludueňa SJ, Pietrasanta LI, Gamarnik AV, (2005) Long-range RNA-RNA interactions circularize the dengue virus genome. J Virol 79: 6631-6643.
34. Doench JG, Petersen CP, Sharp PA, (2003) siRNAs can function as miRNAs. Genes Dev 17: 438-442.
35. Narvaiza I, Aparicio O, Vera M, Razquin N, Bortolanza S, et al. (2006) Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing. J Virol 80: 12236-12247.
36. Schul W, Liu W, Xu HY, Flamand M, Vasudevan SG, (2007) A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis 195: 665-674.
37. Ludert JE, Mosso C, Ceballos-Olvera I, del Angel RM, (2008) Use of a commercial enzyme immunoassay to monitor dengue virus replication in cultured cells. Virol J 5: 51.
38. Lu S, Cullen BR, (2004) Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis. J Virol 78: 12868-12876.
39. Aparicio O, Razquin N, Zaratiegui M, Narvaiza I, Fortes P, (2006) Adenovirus virus-associated RNA is processed into functional interfering RNAs involved in virus production. J Virol 80: 1376-1384.
40. Pilankatta R, Chawla T, Khanna N, Swaminathan S, (2010) The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines. J Med Virol 82: 407-414.
41. Leopold PL, Wendland RL, Vincent T, Crystal RG, (2006) Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway. J Virol 80: 10237-10247.
42. Wu SJL, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, et al. (2000) Human skin Langerhans cells are targets of dengue virus infection. Nature Med 6: 816-820.
43. Chen YC, Wang SY, (2002) Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol 76: 9877-9887.